Dr. Frank Mathias joined Rentschler Biopharma SE’s Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016.
Company increases focus on core operationsChristiane Bardroff to head global clinical and commercial manufacturing, engineering and technology operations, as well as production automation LAUPHEIM, Germany, Nov. 16, 2022 (GLOBE…